Inhibition of mitochondrial fission by Drp-1 blockade by short-term leptin and Mdivi-1 treatment improves white adipose tissue abnormalities in obesity and diabetes. (April 2022)
- Record Type:
- Journal Article
- Title:
- Inhibition of mitochondrial fission by Drp-1 blockade by short-term leptin and Mdivi-1 treatment improves white adipose tissue abnormalities in obesity and diabetes. (April 2022)
- Main Title:
- Inhibition of mitochondrial fission by Drp-1 blockade by short-term leptin and Mdivi-1 treatment improves white adipose tissue abnormalities in obesity and diabetes
- Authors:
- Finocchietto, P.
Perez, H.
Blanco, G.
Miksztowicz, V.
Marotte, C.
Morales, C.
Peralta, J.
Berg, G.
Poderoso, C.
Poderoso, J.J.
Carreras, M.C. - Abstract:
- Abstract: Background: Obesity and type 2 diabetes are chronic diseases characterized by insulin resistance, mitochondrial dysfunction and morphological abnormalities. Objective: We have investigated if dysregulation of mitochondrial dynamics and biogenesis is involved in an animal model of obesity and diabetes. Methods: The effect of short-term leptin and mdivi-1 – a selective inhibitor of Drp-1 fission-protein – treatment on mitochondrial dynamics and biogenesis was evaluated in epididymal white adipose tissue (WAT) from male ob/ob mice. Results: An increase in Drp-1 protein levels and a decrease in Mfn2 and OPA-1 protein expression were observed with enhanced and sustained mitochondrial fragmentation in ob/ob mice compared to wt C57BL/6 animals (p < 0.05). The content of mitochondrial DNA and PGC-1α mRNA expression –both parameters of mitochondrial biogenesis– were reduced in ob/ob mice (p < 0.05). Treatment with leptin and mdivi-1 significantly increased mitochondrial biogenesis, improved fusion-to-fission balance and attenuated mitochondrial dysfunction, thus inducing white-to-beige adipocyte transdifferentiation. Measurements of glucose and lipid oxidation in adipocytes revealed that both leptin and mdivi-1 increase substrates oxidation while in vivo determination of blood glucose concentration showed decreased levels by 50% in ob/ob mice, almost to the wt level. Conclusions: Pharmacological targeting of Drp-1 fission protein may be a potential novel therapeutic tool forAbstract: Background: Obesity and type 2 diabetes are chronic diseases characterized by insulin resistance, mitochondrial dysfunction and morphological abnormalities. Objective: We have investigated if dysregulation of mitochondrial dynamics and biogenesis is involved in an animal model of obesity and diabetes. Methods: The effect of short-term leptin and mdivi-1 – a selective inhibitor of Drp-1 fission-protein – treatment on mitochondrial dynamics and biogenesis was evaluated in epididymal white adipose tissue (WAT) from male ob/ob mice. Results: An increase in Drp-1 protein levels and a decrease in Mfn2 and OPA-1 protein expression were observed with enhanced and sustained mitochondrial fragmentation in ob/ob mice compared to wt C57BL/6 animals (p < 0.05). The content of mitochondrial DNA and PGC-1α mRNA expression –both parameters of mitochondrial biogenesis– were reduced in ob/ob mice (p < 0.05). Treatment with leptin and mdivi-1 significantly increased mitochondrial biogenesis, improved fusion-to-fission balance and attenuated mitochondrial dysfunction, thus inducing white-to-beige adipocyte transdifferentiation. Measurements of glucose and lipid oxidation in adipocytes revealed that both leptin and mdivi-1 increase substrates oxidation while in vivo determination of blood glucose concentration showed decreased levels by 50% in ob/ob mice, almost to the wt level. Conclusions: Pharmacological targeting of Drp-1 fission protein may be a potential novel therapeutic tool for obesity and type 2 diabetes. Graphical Abstract: ga1 Highlights: Mitochondrial dynamic and biogenesis are abnormal in white adipose tissue in this animal model of obesity and type 2 diabetes. Drp-1 fission protein is overexpressed while the fusion- proteins are decreased in this animals. Drp-1 fission protein blocking in white adipose tissue:a new therapeutic target for obesity and diabetes. This molecule should be a new therapeutic target for obesity and type 2 diabetes. … (more)
- Is Part Of:
- Pharmacological research. Volume 178(2022)
- Journal:
- Pharmacological research
- Issue:
- Volume 178(2022)
- Issue Display:
- Volume 178, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 178
- Issue:
- 2022
- Issue Sort Value:
- 2022-0178-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-04
- Subjects:
- AMPK AMP-dependent kinase -- BAT brown adipose tissue -- DAF-FM amino-5-methylamino-2¢, 7¢-difluorofluorescein diacetate -- DRP-1 dynamin-related protein-1 -- FFA free fatty acid -- LC3-II microtubule-associated protein 1A/1B-light chain 3 -- Mdivi-1 selective inhibitor of Drp1 -- Mfn2 mitofusin proteins -- NO nitric oxide -- NRF1 nuclear respiratory factor -- Ob/ob leptin-deficient mice -- OPA-1 optic atrophy-1 -- OXPHOS oxidative phosphorylation system -- PE phosphatidylethanolamine -- PGC-1α proliferator-activated receptor gamma coactivator-1 alpha -- RNS reactive nitrosative species -- ROS reactive oxygen species -- RT-PCR reverse transcription-polymerase chain reaction -- siRNA small interference RNA -- UCP-1 uncoupler protein 1 -- WAT white adipose tissue
White adipose tissue -- Mitochondria -- Biogenesis -- Dynamics -- Drp-1 -- Mdivi-1
Pharmacology -- Periodicals
Pharmacology -- Periodicals
Research -- Periodicals
Médicaments -- Recherche -- Périodiques
Pharmacologie -- Périodiques
615.105 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10436618 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.phrs.2021.106028 ↗
- Languages:
- English
- ISSNs:
- 1043-6618
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6446.550000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21248.xml